Agilis Pharmaceuticals Llp

Agilis Pharmaceuticals Llp - paper in Kandivali West, Maharashtra, India. FY 2026 financials and compliance.
LLPIN ABB-8641 Incorporated 25 July 2022 ROC Mumbai HQ Kandivali West, Maharashtra, India
Pending Strike Off Limited Liability Partnership paper
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
Locked
In full report
Net profit · Latest
Locked
In full report
Contribution obligation
₹1 Lakh
As per LLP agreement
Paid-up contribution
-
Contribution received
Open charges
None
Secured borrowings
Company age
4 yrs
Est. 2022
Last AGM
31 Mar 2023
Annual general meeting

About Agilis Pharmaceuticals Llp

Data last updated: 17 October 2025

Agilis Pharmaceuticals Llp is a limited liability partnership company based in Kandivali West, Maharashtra, India. The LLP is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the LLP may be struck off soon. It specialises in paper and paper products, a part of the broader paper and packaging sector. Incorporated on 25 July 2022.

Registered with ROC Mumbai under LLPIN ABB-8641.

Capital: a total obligation of contribution of ₹1 Lakh. It is led by designated partners Mitesh Jayantilal Doshi and Ruchi Nimish Siria.

Office: Sector 3, Kandivali West, Maharashtra.

The LLP is under the process of being struck off by the Registrar of Companies. This typically indicates non-filing of statutory returns, and the LLP may soon cease to exist as a legal entity.

Company Details of Agilis Pharmaceuticals Llp
LLPIN ABB-8641
Incorporation Date 25 July 2022
Total Obligation of Contribution ₹1 Lakh
ROC Mumbai
Company Status Under Process of Striking Off
Date of Last AGM 31 March 2023
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Off – 136 Kesar Residency Chs Ltd, Sector 3 Near Charkop Market, Kandivali West, Maharashtra, India – 400067
  • Industry
    Paper, Paper & Paper Products, Manufacturing
Company report
Agilis Pharmaceuticals Llp - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Agilis Pharmaceuticals Llp report

Financials, compliance, directors, charges, ownership and filings for Agilis Pharmaceuticals Llp in one report.

10-year financials Directors & ownership Charges & compliance

Designated Partners of Agilis Pharmaceuticals Llp

Agilis Pharmaceuticals Llp is governed by 2 designated partners who oversee the company's operations and strategic decisions.

Current Designated Partners
Name Designation Appointment Date Tenure Status
Mitesh Jayantilal Doshi Designated Partner 25 Jul 2022 4 Years 0 Months Current
Ruchi Nimish Siria Designated Partner 25 Jul 2022 4 Years 0 Months Current

Financials of Agilis Pharmaceuticals Llp

Premium access

Ten-year financial statements for Agilis Pharmaceuticals Llp

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings Agilis Pharmaceuticals Llp

Agilis Pharmaceuticals Llp does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Agilis Pharmaceuticals Llp

View historical data on people associated with Agilis Pharmaceuticals Llp, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Agilis Pharmaceuticals Llp

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Agilis Pharmaceuticals Llp

Premium access

GST registrations and filing compliance for Agilis Pharmaceuticals Llp

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Agilis Pharmaceuticals Llp

Premium access

Credit ratings, litigation, and regulatory alerts for Agilis Pharmaceuticals Llp

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Agilis Pharmaceuticals Llp

Premium access

MSME payment history for Agilis Pharmaceuticals Llp

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Agilis Pharmaceuticals Llp

Premium access

Corporate group structure for Agilis Pharmaceuticals Llp

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Agilis Pharmaceuticals Llp

Premium access

MCA filings and documents for Agilis Pharmaceuticals Llp

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Agilis Pharmaceuticals Llp

Activity
31 Mar 2023
Agilis Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records.
Directors
25 Jul 2022
Mitesh Jayantilal Doshi was appointed as a Designated Partner on 25 Jul 2022 & has been associated with this company since 4 years 14 days.
Directors
25 Jul 2022
Ruchi Nimish Siria was appointed as a Designated Partner on 25 Jul 2022 & has been associated with this company since 4 years 14 days.
Activity
25 Jul 2022
Agilis Pharmaceuticals Llp was registered on 25 Jul 2022 with Roc Mumbai & aged 4 years 14 days as per MCA records.

Frequently Asked Questions about Agilis Pharmaceuticals Llp

Agilis Pharmaceuticals Llp is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the LLP from the register, typically due to non-filing of statutory returns. This process is not yet final, but the LLP may be struck off soon. Caution is advised before entering into any agreements with this entity.

Agilis Pharmaceuticals Llp is a company pending strike off, currently registered as a limited liability partnership in the paper sector based in Kandivali West, Maharashtra, India. It was incorporated on 25 July 2022 and is registered under LLPIN ABB-8641. The LLP may be struck off soon - caution is advised.

The current designated partners of Agilis Pharmaceuticals Llp are:

The LLPIN (Limited Liability Partnership Identification Number) of Agilis Pharmaceuticals Llp is ABB-8641. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

The primary industry of Agilis Pharmaceuticals Llp is paper. The LLP specifically operates in paper and paper products.

Agilis Pharmaceuticals Llp can be reached at the registered office: Off – 136 Kesar Residency Chs Ltd, Sector 3 Near Charkop Market, Kandivali West, Maharashtra, India – 400067.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available